Работы, цитирующие эту работу

Работ: 4

Работа: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

1. The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia

   Yu. I. Feshchenko, Sophio Beridze, Dinh Thi Hoa +9

   СтатьяTrauma, Hemostasis, Coagulopathy, ResuscitationInfusion & Chemotherapy2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.002368

2. The first data on international multicenter clinical study RheoSTAT-CP0620 on the efficacy and safety of Rheosorbilact® infusion in therapy of sepsis

   V. Kh. Sharipova, Sophio Beridze, Олександр Підмурняк +9

   СтатьяSepsis Diagnosis and TreatmentInfusion & Chemotherapy2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.005387

3. The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis

   S Agop, V. Kh. Sharipova, K Kashibadze +7

   СтатьяSepsis Diagnosis and TreatmentPerioperaciina Medicina2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.006123

4. Criteria for choosing antibiotic therapy for surgical sepsis in children

   Э. А. Сатвалдиева, Otabek Ya. Fayziev, Gulchehra Z. Ashurova +2

   СтатьяSepsis Diagnosis and TreatmentRussian Journal of Pediatric Surgery Anesthesia and Intensive Care2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.007046